Assesment of P wave duration and dispersion in Parkinson's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 4, 2006, Pages 718-723

  Kocer, Abdulkadir ^a   Karakaya, Osman ^b   Barutcu, Irfan ^b   Batukan Esen, Ozlem ^c   Kargin, Ramazan ^b   Mayda Domac, Füsun ^d  

^a DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^c MEMORIAL HOSPITAL   (Turkey)

^d HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Atrial arrhythmia; P wave dispersion; P wave duration; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; BENSERAZIDE PLUS LEVODOPA; CABERGOLINE; ENTACAPONE; PERGOLIDE MESILATE; PRIBEDIL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; MALE; P WAVE; PARKINSON DISEASE; PATIENT SELECTION; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 33646100996     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.02.011     Document Type: Article

References (34)

1. Appenzeller O., and Goss J.E. Autonomic deficits in Parkinson's syndrome. Arch Neurol 24 (1971) 50-57
2. Aytemir K., Ozer N., Atalar E., Sade E., Aksoyek S., Ovunc K., et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 1109-1112
3. Braune S., Reinhardt M., Bathmann J., Krause T., Lehmann M., and Lucking C.H. Impaired cardiac uptake of [123I]-metaiodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand 97 (1998) 307-314
4. Chaudhuri K.R. Autonomic dysfunction in movement disorders. Curr Opin Neurol 14 (2001) 505-511
5. Cheema A.N., Ahmed M.W., Kadish A.H., and Goldberger J.J. Effects of autonomic stimulation and blockade on signal-averaged P wave duration. J Am Coll Cardiol 26 (1990) 497-502
6. Deguchi K., Sasaki I., Tsukaguchi M., Kamoda M., Touge T., Takeuchi H., et al. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy. J Neurol Sci 199 (2002) 31-37
7. Dilaveris P.E., and Gialofos J.E. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6 (2001) 159-165
8. Dilaveris P.E., Gialafos E.J., Sideris S., Theopistou A.M., Andrikopoulos G.K., Kyriakidis M., et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135 (1998) 733-738
9. Dilaveris P.E., Gialafos E.J., Andrikopoulos G.K., Richter D.J., Papanikolaou V., Poralis K., et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 352-358
10. Druschky A., Hilz M.J., Platsch G., Radespiel-Troger M., Druschky K., Kuwert T., et al. Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-SPECT. J Neurol Sci 175 (2000) 3-12
11. Fahn S, Elton R. Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease, Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987. pp 153-63, 293-304.
12. Goldstein D.S., and Kopin I.J. Cardiac sympathetic innervation and function in patients with sympathetic neurocirculatory failure and parkinsonism. Neurology 52 suppl 2 (1999) A541
13. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
14. Ishizaki F., Harada T., Yoshinaga H., Nakayama T., Yamamura Y., and Nakamura S. Prolonged QTc intervals in Parkinson's disease-relation to sudden death and autonomic dysfunction. No To Shinkei 48 (1996) 443-448
15. Iwanaga K., Wakabayashi K., Yoshimoto M., Tomita I., Satoh H., Takashima H., et al. Lewy-body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body disease. Neurology 52 (1999) 1269-1271
16. Jellinger K.A. Post mortem studies in Parkinson's disease: is it possible to detect brain areas for specific symptoms?. J Neural Transm 56 (1999) 1-29
17. Kallio M., Souminen K., Haapaniemi T., Sotaniemi K., Myllyla V.V., Astafiev S., et al. Nocturnal cardiac autonomic regulation in Parkinson's disease. Clin Auton Res 14 (2004) 119-124
18. Kuroiwa Y., Shimada Y., and Toyokura Y. Postural hypotension and low R-R interval variability in parkinsonism, spino-cerebellar degeneration, and Shy-Drager syndrome. Neurology 33 (1987) 463-467
19. Leier C.V., Meacham J.A., and Schaal S.F. Prolonged atrial conduction: a major predisposing factor for the development of atrial flutter. Circulation 57 (1978) 213-216
20. Ludin S.M., Steiger U.H., and Ludin H.P. Autonomic disturbances and cardiovascular reflexes in idiopathic Parkinson's disease. J Neurol 235 (1987) 10-15
21. Magalhaes M., Wenning G.K., Daniel S.E., and Quinn N.P. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease. A retrospective comparison. Acta Neurol Scand 91 (1995) 98-102
22. Mastrocola C., Vanacore N., Giovani A., Locuratolo N., Vela C., Alessandri A., et al. Twenty-four hour heart rate variability to assess autonomic function in Parkinson's disease. Acta Neurol Scand 99 (1999) 245-247
23. Meco G., Pratesi L., and Bonifati V. Cardiovascular reflexes and autonomic dysfunction in Parkinson's disease. J Neurol 238 (1991) 195-199
24. Micieli G., Tosi P., Marcheselli S., and Cavallini A. Autonomic dysfunction in Parkinson's disease. Neurol Sci 24 (2003) 32-34
25. Oka H., Yoshioka M., Morita M., Mochio S., and Inoue K. Cardiac sympathetic dysfunction in Parkinson's disease-relationship between results of 123I-MIBI scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver. Rinsho Shinkeigaku 43 (2003) 465-469
26. Okada Y., Ito Y., Aida J., Yasuhara M., Ohkawa S., and Hirokawa K. Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Pathol Int 54 (2004) 682-687
27. Pursiainen V., Haapaniemi T.H., Korpelainen J.T., Huikuri H.V., Sotaniemi K.A., and Myllyla V.V. Circadian heart rate variability in Parkinson's disease. J Neurol 249 (2002) 1535-1540
28. Rajput A.H., and Rozdilsky B. Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry 39 (1976) 1092-1100
29. Siddiqui M.F., Rast S., Lynn M.J., Auchus A.P., and Pfeiffer R.F. Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey. Park Rel Disord 8 (2002) 277-284
30. Singer C., Weiner W.J., and Sanchez-Ramos J.R. Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 32 (1992) 134-140
31. Tukek T., Akkaya V., Demirel S., Sozen A.B., Kudat H., Atilgan D., et al. Effect of valsalva maneuver on surface electrocardiographic P wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 85 (2000) 896-899
32. Turkka J.T., Tolonen U., and Myllyla V.V. Cardiovascular reflexes in Parkinson's disease. Eur Neurol 1 (1987) 104-112
33. Turkka J., Souminen K., Tolonen U., Sotaniemi K., and Myllyla V.V. Selegiline diminishes cardiovascular autonomic responses in Parkinson's disease. Neurology 48 (1997) 662-667
34. van Dijk J.G., Haan J., Zwinderman K., Kremer B., van Hilten B.J., and Roos R.A. Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry 56 (1993) 1090-1095